New Tool: ProSource
Checkout our packaging and processing solutions finder, ProSource.
Start Your Search

Cannabis Terpenes Could Treat COVID-19

Researchers in Israel are testing the efficacy of cannabis terpenes in treating COVID-19 infections.

As the legalization of cannabis spreads throughout the US, and the polarizing plant becomes mainstream, its derivatives are finding new uses in the medical world. A recent L.A. Cannabis News article discussed an Israeli study that’s testing the benefits of using cannabis terpenes to treat inflammatory infections, such as COVID-19. Terpenes are aromatic oils that give cannabis varieties a distinctive flavor. They’re secreted in the same plant glands that produce cannabinoids, like THC and CBD.

The study, conducted by cannabis research and development firms Eybna and Cannasoul, examined how a specific cannabis terpene formulation can treat inflammatory conditions like cytokine storm syndrome, a common occurrence in severe COVID-19 cases. Initial results looked promising, and more information can be found at Health Europa.

Test Your Supply Chain Smarts
Take Healthcare Packaging's supply chain quiz to prove your knowledge!
Take Quiz
Test Your Supply Chain Smarts
Discover Our Content Hub
Access Healthcare Packaging's free educational content library!
Unlock Learning Here
Discover Our Content Hub